SLC9A1 and glioma: Analysis of the RNAseq data revealed that SLC9A1 mRNA expression was higher in glioblastoma than WHO grade II and III gliomas in CGGA cohort (Fig. 1a) as well as in TCGA cohort (Fig. 1b).